All In Biotech

Drug Trial Radar · NCT05835479

Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults

A Phase 2, Proof-of-Concept, Multicentre, Open-Label, Randomised, Active-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Rezafungin Combined With 7 Days of Co-Trimoxazole Versus Co-Trimoxazole Monotherapy in HIV-Infected Adults With Pneumocystis Jirovecii Pneumonia

Last checked: Nov 19, 2026Latest source record: Apr 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Nov 14, 2023

Primary completion

May 2025

Study completion Aug 2025

Sponsor

Lead sponsor
Mundipharma Research LimitedIndustry
Sponsor type
Industry
First posted
Apr 28, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to generate clinical data on the efficacy, safety, and tolerability of rezafungin combined with 7 days of co-trimoxazole for treatment of Pneumocystis pneumonia (PCP) in adults living with human immunodeficiency virus (HIV), which would expand the knowledge of clinical use of rezafungin.

Conditions

  • Pneumocystis Pneumonia

Interventions

  • Co-TrimoxazoleDrug

    Oral co-trimoxazole or Intravenous (IV) co-trimoxazole for infusion. Anti fungal medication

  • Rezafungin Acetate / Co TrimoxazoleDrug

    Rezafungin for infusion. Intravenous anti fungal therapy Oral co-trimoxazole or Intravenous (IV) co-trimoxazole for infusion. Anti fungal medication

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Therapeutic failure on Day 8Time frame: 8 days

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • University of Cape Town

    Cape Town, South Africa · Recruiting

  • Charlotte Maxeke Johannesburg Academic Hospital

    Johannesburg, South Africa · Recruiting

  • Helen Joseph Hospital

    Johannesburg, South Africa · Terminated

  • Global Clinical Trials - Pretoria

    Pretoria, South Africa · Recruiting

  • Steve Biko Academic Hospital

    Pretoria, South Africa · Recruiting

  • Netcare Umhlanga Medical Centre

    Umhlanga, South Africa · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.